12 completed, 2 withdrawn. 7 Phase 1, 7 Phase 2.
By phase and status
Follow PH 797804: new trials by email Literature Review of PH 797804 trials Research Report on PH 797804
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix .
Trial Phase Status Sponsor Enrollment Start Updated
A Pharmacokinetic Study of Three Different Particle Sizes of PH-797804 PH-797804 - Healthy Phase 1 Withdrawn Pfizer 2014-03-01 2013-12-20 A Study to Investigate the Effect of PH-797804 on QTc Interval PH-797804, Moxifloxacin, Placebo - Healthy Phase 1 Completed Pfizer 48 2013-04-01 2013-08-15 A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804 PH-797804, PH-797804 + erythromycin - Healthy Phase 1 Completed Pfizer 12 2012-06-01 2012-08-17 Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide PH-797804, Placebo - Pulmonary Disease, Chronic Obstructive Phase 2 Completed Pfizer 730 2012-04-01 2014-10-27 A Study To Investigate The Effect Of Food On The Pharmacokinetics Of PH-797804 PH-797804 - Healthy Volunteers Phase 1 Completed Pfizer 28 2011-12-01 2012-02-28 Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate Combination PH-797804, Placebo - Pulmonary Disease, Chronic Obstructive Phase 2 Completed Pfizer 377 2011-05-01 2013-07-11 Single Dose Lipopolysaccharide (LPS) Study In Healthy Volunteers PF-03715455, PH-797804, Placebo for PF-03715455 - Chronic Obstructive Pulmonary Disease (COPD) Phase 1 Completed Pfizer 39 2011-01-01 2012-02-02 Clinical Trial to Examine the Pain Relief of PH-797804 Alone Or With Naproxen in Subjects With Osteoarthritis of the Knee PH-797804, Placebo, Naproxen - Osteoarthritis Phase 2 Completed Pfizer 172 2010-05-01 2014-08-22 Relative Bioavailability and Food Effect Study PH797804 - Pain Phase 1 Withdrawn Pfizer 2009-02-01 2015-03-05 PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia PH-797804, Placebo - Neuralgia, Postherpetic Phase 2 Completed Pfizer 80 2008-04-01 2011-05-16 A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking Methotrexate Placebo, PH-797804 - Arthritis, Rheumatoid Phase 2 Completed Pfizer 27 2008-03-01 2018-11-08 A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD). PH-797804, Placebo - Chronic Obstructive Pulmonary Disease Phase 2 Completed Pfizer 230 2008-02-01 2018-10-16 An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis placebo, PH-797804 - Arthritis, Rheumatoid Phase 2 Completed Pfizer 305 2006-12-15 2021-08-20 PH-797804 LPS Study in Healthy Volunteers PH-797804, Placebo - Healthy Phase 1 Completed Pfizer 24 2006-09-01 2014-03-14
Conditions studied Pulmonary Disease, Chronic Obstructive (5) · Arthritis, Rheumatoid (2) · Arthritis (1) · Neuralgia, Postherpetic (1) · Osteoarthritis (1) · Osteoarthritis, Knee (1) · Pain (1)
Sponsors Pfizer (14)
Countries United Kingdom (5) · United States (5) · Chile (4) · Czechia (4) · South Africa (4) · Argentina (3) · Australia (3) · Canada (3) · Hungary (3) · Poland (3) · Russia (3) · Spain (3) · Sweden (3) · Bulgaria (2) · India (2)
Results publications PMID 23539534